Bluepha is a biomanufacturing and material innovation company providing breakthrough products with competitive differentiation. We are using an array of cutting-edge technologies including synthetic biology, data science and automation, to constantly deliver values for Fortune 500 companies with over $1 billion worth of products meeting innovative demands in consumer goods, healthcare, agriculture, electronics and more. By working across boundaries to create materials of the future, Bluepha brings substantial and sustainable solutions for current and future generations. At Bluepha, we create life for the future.
Location: China, Beijing
Employees: 51-200
Total raised: $235M
Founded date: 2016
Investors 3
| Date | Name | Website |
| 05.02.2022 | Lightspeed... | lsvp.com |
| 26.09.2022 | Plug and P... | plugandpla... |
| - | Lightspeed... | lightspeed... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.01.2022 | Series B | $235M | Genesis Ca... |
Mentions in press and media 3
| Date | Title | Description |
| 16.02.2023 | Tencent-backed Bluepha snaps $58m in extended Series B round | Beijing-based biomaterial firm Bluepha has snapped 400 million yuan ($58.3 million) in an extended Series B round led by Zhong Ping Capital. The round, joined by state-owned Jiangsu Huanghai Financial Holding Group, has brought the firm’s t... |
| 10.01.2022 | Bluepha Secures Round-B Financing of 1.5 Billion Yuan | Leading Chinese synthetic biology firm Bluepha announced today that it has completed a B3 round of financing, bringing total round-B funds to 1.5 billion yuan ($235 million). Bluepha’s B3 round was jointly led by Genesis Capital and China S... |
| - | Bluepha | “Blue crystal microorganisms based on synthetic biology technology molecular and material innovation enterprises” |